Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Multiple Sclerosis Diagnostic Delay and MisdiagnosisRecent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis
Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA
Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment
Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders
Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies
Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion
Bruton's Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment: A New Frontier
Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis
Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment?
Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis
Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable
Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis
Women's Health and Pregnancy in Multiple Sclerosis
Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved
Era of COVID-19 in Multiple Sclerosis Care

